Pileri A - Search Results

1

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage.

Ladetto M, De Marco F, Benedetti F, Vitolo U, Patti C, Rambaldi A, Pulsoni A, Musso M, Liberati AM, Olivieri A, Gallamini A, Pogliani E, Rota Scalabrini D, Callea V, Di Raimondo F, Pavone V, Tucci A, Cortelazzo S, Levis A, Boccadoro M, Majolino I, Pileri A, Gianni AM, Passera R, Corradini P, Tarella C; Gruppo Italiano Trapianto di Midollo Osseo (GITMO); Intergruppo Italiano Linfomi (IIL). Ladetto M, et al. Among authors: pileri a. Blood. 2008 Apr 15;111(8):4004-13. doi: 10.1182/blood-2007-10-116749. Epub 2008 Jan 31. Blood. 2008. PMID: 18239086 Free article. Clinical Trial.

2

[Kinetic and immunological studies in human myeloma: clinical implications (author's transl)].

Pileri A, Boccadoro M. Pileri A, et al. Haematologica. 1979 Oct;64 Suppl:30-4. Haematologica. 1979. PMID: 120281 Italian. No abstract available.

3

Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.

Gianni AM, Bregni M, Siena S, Magni M, Di Nicola M, Lombardi F, Tarella C, Pileri A, Bonadonna G. Gianni AM, et al. Among authors: pileri a. J Clin Oncol. 1992 Dec;10(12):1955-62. doi: 10.1200/JCO.1992.10.12.1955. J Clin Oncol. 1992. PMID: 1280674

4

Self-renewal inhibition of acute myeloid leukemia clonogenic cells by biological inducers of differentiation.

Ferrero D, Carlesso N, Pregno P, Gallo E, Pileri A. Ferrero D, et al. Among authors: pileri a. Leukemia. 1992 Feb;6(2):100-6. Leukemia. 1992. PMID: 1372669

5

Multiple myeloma: intensified maintenance therapy with recombinant interferon-alpha-2b plus glucocorticoids.

Palumbo A, Boccadoro M, Garino LA, Gallone G, Frieri R, Pileri A. Palumbo A, et al. Among authors: pileri a. Eur J Haematol. 1992 Aug;49(2):93-7. doi: 10.1111/j.1600-0609.1992.tb00037.x. Eur J Haematol. 1992. PMID: 1397246 Clinical Trial.

6

Early disappearance of murine plasmocytoma stem cells in long-term bone marrow culture.

Tarella C, Omedè P, Boccadoro M, Palumbo A, Battaglio S, Pileri A. Tarella C, et al. Among authors: pileri a. Leuk Res. 1992 Aug;16(8):743-50. doi: 10.1016/0145-2126(92)90152-w. Leuk Res. 1992. PMID: 1528062

7

Standard chemotherapy for myelomatosis: an area of great controversy.

Boccadoro M, Pileri A. Boccadoro M, et al. Among authors: pileri a. Hematol Oncol Clin North Am. 1992 Apr;6(2):371-82. Hematol Oncol Clin North Am. 1992. PMID: 1582979 Review.

8

C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system.

Bataille R, Boccadoro M, Klein B, Durie B, Pileri A. Bataille R, et al. Among authors: pileri a. Blood. 1992 Aug 1;80(3):733-7. Blood. 1992. PMID: 1638024 Free article.

9

MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapse.

Tarella C, Gallo E, Ferrero D, Badoni R, Carlesso N, Caracciolo D, Pileri A. Tarella C, et al. Among authors: pileri a. Haematologica. 1990 Mar-Apr;75(2):149-54. Haematologica. 1990. PMID: 1694155

10

Analysis of immunoglobulin heavy chain gene rearrangement using the polymerase chain reaction.

Corradini P, Boccadoro M, Pileri A. Corradini P, et al. Among authors: pileri a. Blood. 1992 Jan 1;79(1):291-2. Blood. 1992. PMID: 1728319 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

442 results

Search Page

Filters